PROTEOMICS AT YOUR
FINGERSTIPS
Starting with ProteoMix™ RUO kits as our first commercial product, we will expand into point-of-care and true at-home systems — ushering in the era of distributed and telehealth diagnostics.
ONE SCALABLE PLATFORM.
TWO MASSIVE MARKETS.
Research proteomics and clinical immunoassay diagnostics represent a >$200B long-term market, with an addressable opportunity of ~$60B — powered by ProteoNex™ chemistry.
FIRST PRODUCT:
PROTEOMIX™
MULTIPLEX KITS
We’re developing RUO kits for biopharma research, bringing a 10 min, multiplex protein measurement to 300,000+ qPCR instruments already used in laboratories.
Leverages
Existing
Infrastructure
No Additional
Hardware
Needed
Efficient and
Cost-Effective
Built for
Scalable
Roadmap
PROTEONEX™
TECHNOLOGY
eGlint’s ProteoNex™ platform uses aptamer-based biosensors on high-density microarrays to measure combinations of virtually any protein biomarkers.
General and
Quantitative
Quantifies virtually any biomarker from a blood sample
Highly
Multiplexed
Performs hundreds of assays at once
Simple and
Rapid
Delivers results within minutes without sample purification
Affordable and
Scalable
Lowers cost per sample and dramatically lowers cost per biomarker
PROTEOMICS TODAY IS TOO SLOW, TOO HARD, AND TOO LIMITED.
WE FIX THAT.
ProteoNex™ is a 10-minute, multiplex, one-step assay —
at a fraction of ELISA's cost
LEADERSHIP TEAM
eGlint is led by repeat operators with $3.7B in combined exits
and multiple Dx products launched.
Executive Team
$4.6M RAISED TO DATE
Building toward commercialization of our first ProteoMix™ product
INDUSTRY VALIDATION.
COMMERCIAL PROGRESS
Completed industry studies and customer discovery with select products are advancing to commercialization.
✔
Pilot completed and partnership established with a leading life science tools company, confirming compatibility of our platform and robust assay performance.
✔
Technical and strategic validation by a major industry player following deep diligence.
✔
Successfully completed a feasibility study with a major IVD company measuring a cytokine in clinical samples.
✔
Named a “Cool Company 2025” by Connect San Diego.
